Domínguez GMA, Navarrete FG, Zuloeta EMEI

Language: Spanish
References: 14
Page: 27-29
PDF size: 70.95 Kb.

ABSTRACT

We report a case of 48 year old female with diagnosis of eruptive xanthomas and diabetes mellitus 2, showing the importance of its like a cutaneous marker of systemic disease.

REFERENCES

1. Rook A, Wilinson DS, Ebling FJ. Tratado de dermatología. 4ª. Ed., Doyma, Barcelona: 2472-2477.

2. Moschella SM, Hurley HJ. Dermatology. 3a. Edición. W.B. Saunders Co. Philadelphia: 1641-1658.

3. Robson KJ, Piette WW. Cutaneous manifestations of systemic diseases. Medical Clinics of North America 1998; 82: 1359-1375.

4. Pupo RA, Wiss K, Solomon AR. Disorders affecting the skin and the heart. Dermatologic clinics 1989; 7: 517-529.

5. Rivera L, Aguilar SC. Diagnóstico y tratamiento de las dislipidemias, Diplomado en Farmacoterapia, Asociación Mexicana para la Comunicación y el Periodismo Médico A.C.: 16-21.

6. Callen JP. Cutaneous aspects of internal disease. Year Book Medical Publishers Inc. Chicago 1981: 473-489.

7. Braverman IM. Skin signs of systemic disease, Saunders WB. Co. Philadelphia 1970: 384-397.

8. Parker F. Xanthomas and hiperlipidemias. J Am Acad Dermatol 1985; 13: 20-28.

9. Schepers GC, Soler CJ. Erupción papulo-tumoral amarillenta. Piel 1995; 10: 479-482.

10. Giménez J, Casanova L, Sánchez M. Xantomas eruptivos secundarios a diabetes mellitus. Acta Dermo-Sif 1982; 73: 163-168.

11. Ríos BL, Arranz MA, Sánchez PJ. Xantomas eruptivos. Actas Dermo-Sif. 1994; 85: 402-406.

12. Toussaint SC, Ahumada MA. Xantomas: marcadores cutáneos de hiperlipidemias. Dermatol Rev Mex 1994; 38: 182-189.

13. Vignale RA, Alallón W, Corbo C. Xantomas e hiperlipoproteinemias primarias. Piel 1987; 2: 73-84.

14. Gutiérrez FD, Jurado SC, Flores O. Dislipoproteinemias, Rev C Dermatol Pascua 1996; 5: 147-153.